Global Blood Preparation Market to Reach US$ 64.9 Billion by 2032, Impelled by Increasing Demand for Blood Transfusion

September 26, 2022 | Healthcare

According to the latest report by IMARC Group, titled “Blood Preparation Market Report by Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic and Anticoagulants Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants), Antithrombotic and Anticoagulants Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others), and Region 2024-2032," the global blood preparation market reached a value of US$ 44.4 Billion in 2023. Blood preparation refers to the process of separating components from one unit of whole blood using the centrifugation technique. Red blood cells (RBCs), platelets, fresh frozen plasma (FFP), cryoprecipitated anti-hemophilic factor (AHF), and granulocytes are some of the components separated using the process. Blood preparation is carried out for transfusion, component therapy, and manufacturing pharmaceuticals. It maximizes the utility of one whole blood unit, increases the therapeutic efficacy of components, and benefits multiple patients simultaneously. Blood preparation also involves the modification of components using irradiation, leukoreduction, and pathogen inactivation to improve the quality during storage and reduce adverse effects, such as allergic reactions.

Global Blood Preparation Market Trends:

The increasing demand for blood transfusion due to the rising prevalence of blood disorders, such as anemia, hemophilia, leukocytosis, sickle cell disease, and cancer, is one of the key factors driving the market growth. In addition, the rising adoption of blood transfusion during surgical procedures, accidents, and injuries due to extreme blood loss is acting as another growth-inducing factor. Furthermore, the COVID-19 pandemic surged the demand for convalescent plasma as a potential treatment for critical patients, which is providing a considerable boost to the market growth. Additionally, the integration of automation technologies to improve blood processing, minimize errors, and increase efficiency by eliminating repetitive tasks, such as weighing, balancing, centrifugation, expression, and sealing, is creating a positive outlook for the market. Moreover, increasing initiatives by several governments to develop plasma-derived proteins, such as immunoglobulins, coagulation factor products, human fibrin foam, dried human plasma, and human thrombin, are providing an impetus to market growth. Other factors, including increasing demand for blood component therapy, significant growth in the pharmaceutical industry, and rapid development of healthcare infrastructure, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 64.9 Billion by 2032, exhibiting a CAGR of 4.2% during 2024-2032.

Market Summary:

  • On the basis of the product, the market has been divided into whole blood (red cells, granulocytes, plasma, and platelets), blood components (whole blood components, packed red cells, leukocyte reduced red blood cells, frozen plasma, platelet concentrate, and cryoprecipitate), and blood derivatives.
  • Based on the antithrombotic and anticoagulants type, the market has been categorized into platelet aggregation inhibitors (glycoprotein inhibitors, COX inhibitors, ADP antagonists, and others), fibrinolytics (tissue plasminogen activator (TPA), streptokinase, and urokinase), and anticoagulants (heparins, vitamin K antagonists, direct thrombin inhibitors, and direct factor Xa inhibitors).
  • On the basis of antithrombotic and anticoagulants application, the market has been classified into thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, and others.
  • On a regional basis, the market has been categorized into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and Others) Latin America (Brazil, Mexico, and Others), and Middle East and Africa.
  • The competitive landscape of the industry has also been examined, with some of the key players being Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.) and Sanofi S.A.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.) and Sanofi S.A
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Blood Preparation Market to Reach US$ 64.9 Billion by 2032, Impelled by Increasing Demand for Blood Transfusion
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More